Ocular Therapeutix, Inc. (OCUL)
10.77
+0.28
(+2.67%)
USD |
NASDAQ |
Sep 14, 12:39
Ocular Therapeutix Price : 10.77 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 10.75 | 10.94 | 10.36 | 10.49 | 2.639M |
| Sep 10, 2026 | 11.43 | 11.43 | 10.54 | 10.62 | 2.392M |
| Sep 09, 2026 | 11.24 | 11.48 | 11.02 | 11.47 | 2.805M |
| Sep 08, 2026 | 10.56 | 11.44 | 10.40 | 11.37 | 2.737M |
| Sep 04, 2026 | 10.51 | 10.77 | 10.51 | 10.64 | 1.307M |
| Sep 03, 2026 | 10.98 | 11.08 | 10.42 | 10.64 | 2.129M |
| Sep 02, 2026 | 10.58 | 11.01 | 10.47 | 10.90 | 2.069M |
| Sep 01, 2026 | 10.42 | 10.66 | 10.32 | 10.57 | 1.578M |
| Aug 31, 2026 | 10.30 | 10.54 | 10.13 | 10.49 | 1.521M |
| Aug 28, 2026 | 10.97 | 10.97 | 10.33 | 10.36 | 1.564M |
| Aug 27, 2026 | 10.63 | 10.96 | 10.57 | 10.82 | 1.427M |
| Aug 26, 2026 | 10.79 | 10.90 | 10.68 | 10.77 | 1.368M |
| Aug 25, 2026 | 10.98 | 11.17 | 10.87 | 10.88 | 1.842M |
| Aug 24, 2026 | 11.03 | 11.05 | 10.61 | 10.78 | 2.358M |
| Aug 21, 2026 | 11.10 | 11.49 | 10.94 | 11.08 | 3.051M |
| Aug 20, 2026 | 11.52 | 11.62 | 11.07 | 11.09 | 3.295M |
| Aug 19, 2026 | 11.29 | 11.74 | 11.18 | 11.73 | 3.024M |
| Aug 18, 2026 | 10.50 | 11.22 | 10.30 | 11.01 | 4.583M |
| Aug 17, 2026 | 10.80 | 11.20 | 10.50 | 10.65 | 11.15M |
| Aug 14, 2026 | 10.04 | 10.07 | 9.68 | 10.04 | 1.634M |
| Aug 13, 2026 | 10.27 | 10.43 | 10.08 | 10.10 | 2.585M |
| Aug 12, 2026 | 9.77 | 10.43 | 9.74 | 10.23 | 4.006M |
| Aug 11, 2026 | 9.29 | 9.77 | 9.16 | 9.76 | 2.180M |
| Aug 10, 2026 | 9.20 | 9.305 | 9.04 | 9.24 | 1.530M |
| Aug 07, 2026 | 8.80 | 9.20 | 8.80 | 9.19 | 2.017M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| EyePoint, Inc. | 4.29 |
| Merck & Co., Inc. | 145.29 |
| Theravance Biopharma, Inc. | 17.02 |
| LENZ Therapeutics, Inc. | 4.52 |
| ANI Pharmaceuticals, Inc. | 71.71 |
Price Related Metrics
| PS Ratio | 44.27 |
| PEG Ratio | -0.7192 |
| Price to Book Value | 4.548 |
| Earnings Yield | -13.12% |
| Market Cap | 2.365B |
| PEGY Ratio | -0.7192 |